 |
|
|
| |
SOFOSBUVIR PLUS VELPATASVIR FOR CHRONIC HCV GENOTYPE 1, 2, 3, AND 4 INFECTION
|
| |
| |
Reported by Jules Levin
EASL 2016 Barcelona April 14-17
Hussien Ahmed1,2,3, Arwa Mohamed1,2, Attia Attia1,4, Ahmed Negida1,2,3 *
[1] Medical Research Group of Egypt; [2] Faculty of Medicine, Zagazig University; [3] Student Research Unit, Zagazig University;[4] Faculty of Medicine, Al Azhar University.
|
| |
|
|
|
|
|
